Andersons pediatric cardiology 1682

cardiomyopathy J Cardiovasc Magn Reson 2015;17:34 304 Toro-Salazar OH, Gillan E, O'Loughlin MT, et al Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy Circ Cardiovasc Imaging 2013;6(6):873–880 305 Olivieri LJ, Kellman P, McCarter RJ, et al Native t1 values identify myocardial changes and stratify disease severity in patients with duchenne muscular dystrophy J Cardiovasc Magn Reson 2016;18(1):72 306 Tandon A, Villa CR, Hor KN, et al Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy J Am Heart Assoc 2015;4(4):e001338 307 Giardini A, Fenton M, Andrews RE, Derrick G, Burch M Peak oxygen uptake correlates with survival without clinical deterioration in ambulatory children with dilated cardiomyopathy Circulation 2011;124(16):1713–1718 308 Chen CK, Manlhiot C, Russell JL, et al The utility of cardiopulmonary exercise testing for the prediction of outcomes in ambulatory children with dilated cardiomyopathy Transplantation 2017 309 Kirk R, Dipchand AI, Rosenthal DN, et al The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary [corrected] J Heart Lung Transplant 2014;33(9):888–909 310 Miyamoto SD, Stauffer BL, Nakano S, et al Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy Eur Heart J 2014;35(1):33–41 311 Zannad F, McMurray JJ, Krum H, et al Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 2011;364(1):11–21 312 Pitt B, Zannad F, Remme WJ, et al The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized aldactone evaluation study investigators N Engl J Med 1999;341(10):709–717 313 Raman SV, Hor KN, Mazur W, et al Eplerenone for early cardiomyopathy in duchenne muscular dystrophy: a randomised, double-blind, placebocontrolled trial Lancet Neurol 2015;14:153– 161 314 CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure Results of the cooperative north scandinavian enalapril survival study (CONSENSUS) N Engl J Med 1987;316(23):1429–1435 315 Investigators S, Yusuf S, Pitt B, et al Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 1991;325(5):293– 302 316 Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 2001;345(23):1667– 1675 317 Pfeffer MA, Swedberg K, Granger CB, et al Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme Lancet 2003;362(9386):759–766 318 Harmon WG, Sleeper LA, Cuniberti L, et al Treating children with idiopathic dilated cardiomyopathy (from the pediatric cardiomyopathy registry) Am J Cardiol 2009;104(2):281–286 319 Puggia I, Merlo M, Barbati G, et al Natural history of dilated cardiomyopathy in children J Am Heart Assoc 2016;5(7)  ... Kirk R, Dipchand AI, Rosenthal DN, et al The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary [corrected] J Heart Lung Transplant 2014;33(9):888–909... Harmon WG, Sleeper LA, Cuniberti L, et al Treating children with idiopathic dilated cardiomyopathy (from the pediatric cardiomyopathy registry) Am J Cardiol 2009;104(2):281–286 319 Puggia I, Merlo M, Barbati G, et al